Literature DB >> 25768357

Prehospital aspirin use and acute respiratory distress syndrome--a case for aspirin in the drinking water?

Jessica A Palakshappa1, Jason D Christie.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2015        PMID： 25768357      PMCID： PMC4360909          DOI： 10.1097/CCM.0000000000000835

Source DB:  PubMed          Journal:  Crit Care Med        ISSN： 0090-3493            Impact factor:   7.598


× No keyword cloud information.
  12 in total

Review 1.  Frequency, type and clinical importance of medication history errors at admission to hospital: a systematic review.

Authors:  Vincent C Tam; Sandra R Knowles; Patricia L Cornish; Nowell Fine; Romina Marchesano; Edward E Etchells
Journal:  CMAJ       Date:  2005-08-30       Impact factor: 8.262

2.  Association of prehospitalization aspirin therapy and acute lung injury: results of a multicenter international observational study of at-risk patients.

Authors:  Daryl J Kor; Jason Erlich; Michelle N Gong; Michael Malinchoc; Rickey E Carter; Ognjen Gajic; Daniel S Talmor
Journal:  Crit Care Med       Date:  2011-11       Impact factor: 7.598

3.  Complete reversal of acid-induced acute lung injury by blocking of platelet-neutrophil aggregation.

Authors:  Alexander Zarbock; Kai Singbartl; Klaus Ley
Journal:  J Clin Invest       Date:  2006-12       Impact factor: 14.808

4.  Unintended medication discrepancies at the time of hospital admission.

Authors:  Patricia L Cornish; Sandra R Knowles; Romina Marchesano; Vincent Tam; Steven Shadowitz; David N Juurlink; Edward E Etchells
Journal:  Arch Intern Med       Date:  2005-02-28

5.  Prehospital aspirin use is associated with reduced risk of acute respiratory distress syndrome in critically ill patients: a propensity-adjusted analysis.

Authors:  Wei Chen; David R Janz; Julie A Bastarache; Addison K May; Hollis R O'Neal; Gordon R Bernard; Lorraine B Ware
Journal:  Crit Care Med       Date:  2015-04       Impact factor: 7.598

6.  Prehospital statin and aspirin use and the prevalence of severe sepsis and acute lung injury/acute respiratory distress syndrome.

Authors:  Hollis R O'Neal; Tatsuki Koyama; Elizabeth A S Koehler; Edward Siew; Blake R Curtis; Richard D Fremont; Addison K May; Gordon R Bernard; Lorraine B Ware
Journal:  Crit Care Med       Date:  2011-06       Impact factor: 7.598

7.  Aspirin effect on early and late changes in acute lung injury in sheep.

Authors:  G L Chelucci; S Boncinelli; M Marsili; P Lorenzi; A Allegra; M Linden; A Chelucci; V Merciai; F Cresci; C Rostagno
Journal:  Intensive Care Med       Date:  1993       Impact factor: 17.440

8.  Antiplatelet therapy is associated with decreased transfusion-associated risk of lung dysfunction, multiple organ failure, and mortality in trauma patients.

Authors:  Jeffrey N Harr; Ernest E Moore; Jeffrey Johnson; Theresa L Chin; Max V Wohlauer; Ronald Maier; Joseph Cuschieri; Jason Sperry; Anirban Banerjee; Christopher C Silliman; Angela Sauaia
Journal:  Crit Care Med       Date:  2013-02       Impact factor: 7.598

9.  Platelet depletion and aspirin treatment protect mice in a two-event model of transfusion-related acute lung injury.

Authors:  Mark R Looney; John X Nguyen; Yongmei Hu; Jessica A Van Ziffle; Clifford A Lowell; Michael A Matthay
Journal:  J Clin Invest       Date:  2009-10-05       Impact factor: 14.808

10.  Lung Injury Prevention with Aspirin (LIPS-A): a protocol for a multicentre randomised clinical trial in medical patients at high risk of acute lung injury.

Authors:  Daryl Jon Kor; Daniel S Talmor; Valerie M Banner-Goodspeed; Rickey E Carter; Richard Hinds; Pauline K Park; Ognjen Gajic; Michelle N Gong
Journal:  BMJ Open       Date:  2012-09-04       Impact factor: 2.692
View more
  1 in total

1.  A Missense Genetic Variant in LRRC16A/CARMIL1 Improves Acute Respiratory Distress Syndrome Survival by Attenuating Platelet Count Decline.

Authors:  Yongyue Wei; Paula Tejera; Zhaoxi Wang; Ruyang Zhang; Feng Chen; Li Su; Xihong Lin; Ednan K Bajwa; B Taylor Thompson; David C Christiani
Journal:  Am J Respir Crit Care Med       Date:  2017-05-15       Impact factor: 21.405
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.